Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ono Pharmaceutical
Biotech
Equillium delivers new lupus data to Ono's doorstep
Equillium’s add-on lupus treatment improved a biomarker of kidney function in an unblinded phase 1 study, setting the ball rolling toward Ono.
Max Bayer
Apr 1, 2024 10:53am
Ono taps Shattuck for $227M bifunctional fusion protein deal
Feb 13, 2024 8:29am
Japan's Ono signs up for KSQ's preclinical cancer programs
Jan 25, 2023 9:55am
Equillium is no longer buying Metacrine, citing new cash
Dec 27, 2022 4:00pm
Ono inks deal for antibody against ‘very challenging’ I-O target
Mar 31, 2022 7:58am
Vasella helps Numab to CHF22M round ahead of cancer trial start
Mar 9, 2020 7:00am